Institutional members access full text with Ovid®

Share this article on:

Antiplatelet and Anticoagulant Drugs for Prevention of Restenosis/Reocclusion After Peripheral Endovascular Treatment

Andrews, Lesley RN, SPQ (Renal), BSc, PGDip, PGCert

Section Editor(s): Fowler, Susan B. PhD, RN, CNRN, FAHA

doi: 10.1097/NUR.0b013e31828c83b6
Departments: Cochrane Nursing Care Corner

Author Affiliation: School of Nursing,Midwifery and Health, University of Stirling, Scotland, United Kingdom.

The author is a member of the Cochrane Nursing Care Field (CNCF).

The author reports no conflicts of interest.

Correspondence: Susan B. Fowler, PhD, RN, CNRN, FAHA, New York Eye and Ear Infirmary, 310 E 14th St, New York, NY 10031 (njfowlers761@ msn.com).

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins